Skip to main content
. 2021 Apr 15;2021(4):CD013346. doi: 10.1002/14651858.CD013346.pub2

Beneduce 2008.

Study characteristics
Patient Sampling Serum samples from 31 patients with cirrhosis, 33 untreated HCC and 30 healthy controls were studied. 
Age range not reported. Males 75%
Patient characteristics and setting  
Index tests Serum AFP levels were determined using AFP ELISA kit (DRG Diagnostics)
Target condition and reference standard(s) HCC was diagnosed by ultrasound, computed tomography and/or magnetic resonance and confirmed by histopathology, when indicated.
Flow and timing No information on interval between index test and reference standard
Comparative  
Notes Some authors are employed by XEPTAGEN SpA, Marghera Venezia, Italy (L. Beneduce, G. Pesce, A. Gallotta, F. Zampieri, G. Fassina).
Methodological quality
Item Authors' judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? No    
Was a case‐control design avoided? No    
Did the study avoid inappropriate exclusions? Unclear    
Could the selection of patients have introduced bias?   High risk  
Are there concerns that the included patients and setting do not match the review question?     Low concern
DOMAIN 2: Index Test (AFP)
Were the index test results interpreted without knowledge of the results of the reference standard? Unclear    
If a threshold was used, was it pre‐specified? Yes    
Could the conduct or interpretation of the index test have introduced bias?   Unclear risk  
Are there concerns that the index test, its conduct, or interpretation differ from the review question?     Low concern
DOMAIN 2: Index Test (US+AFP)
DOMAIN 2: Index Test (US)
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target condition? Yes    
Were the reference standard results interpreted without knowledge of the results of the index tests? Unclear    
Could the reference standard, its conduct, or its interpretation have introduced bias?   Unclear risk  
Are there concerns that the target condition as defined by the reference standard does not match the question?     Low concern
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and reference standard? Unclear    
Did all patients receive the same reference standard? Unclear    
Were all patients included in the analysis? Unclear    
Could the patient flow have introduced bias?   Unclear risk